Edition:
United States

ReproCell Inc (4978.T)

4978.T on Tokyo Stock Exchange

384JPY
2:00am EDT
Change (% chg)

¥-6 (-1.54%)
Prev Close
¥390
Open
¥389
Day's High
¥390
Day's Low
¥382
Volume
262,000
Avg. Vol
482,537
52-wk High
¥592
52-wk Low
¥364

Latest Key Developments (Source: Significant Developments)

ReproCell says exercise of options
Monday, 17 Apr 2017 02:11am EDT 

April 17 (Reuters) - ReproCell Inc <4978.T> ::* Says 610 of its 12th series options were exercised into 610,000 shares, during the period from April 3 to April 17.  Full Article

ReproCell announces exercise of options
Tuesday, 28 Mar 2017 02:05am EDT 

ReproCell Inc <4978.T>:Says 670 of 12th warrants were exercised into 670,000 shares of its common shares from March 1 to March 28, comprised of 50,000 shares at exercise price 396 yen, 90,000 shares at 392 yen, 220,000 shares at 390 yen, 40,000 shares at 381 yen, 20,000 shares at 377 yen, 50,000 shares at 373 yen, 50,000 shares at 370 yen and 150,000 shares at exercise price 362 yen.  Full Article

ReproCELL announces exercise of warrants
Thursday, 19 Jan 2017 01:00am EST 

ReproCELL Inc <4978.T> :Says 680 of its 12th series warrants were exercised into 680,000 shares, during the period from Jan. 5 to Jan. 19.  Full Article

ReproCell signs cooperation contract with Taiwan firm Steminent Biotherapeutics Inc.
Friday, 11 Nov 2016 01:00am EST 

ReproCell Inc <4978.T>: Says it signed cooperation contract with Taiwan-based firm Steminent Biotherapeutics Inc. . Says two parties to jointly develop and sell a cell pharmaceutical product of Steminent Biotherapeutics Inc. .Says the co is going to start the business in regenerative medicine field.  Full Article

ReproCell announces merger among 3 subsidiaries
Monday, 1 Aug 2016 02:00am EDT 

ReproCell Inc <4978.T>: Says its 71.6 percent owned subsidiary, Bioserve Biotehnologies, Ltd., will merge with two other wholly owned subsidiaries, Stemgent Inc. and Biopta Inc. . Says after the transaction, Bioserve Biotehnologies, Ltd. will be the surviving company, Stemgent Inc. and Biopta Inc. will be dissolved . Bioserve Biotehnologies, Ltd. will change company name into ReproCELL U.S.A. Inc., and ReproCell will hold 92.55 percent stake in ReproCELL U.S.A. .Effective date Sep. 1.  Full Article

ReproCell announces merger between two UK-based units
Monday, 6 Jun 2016 04:12am EDT 

ReproCell Inc <4978.T>: Says a UK-based unit Biopta Ltd., which is engaged in the drug-discovery support services, will undertake a merger with another UK-based unit Reinnervate Ltd on July 1 .Says both of the units are wholly owned by the company and the unit's name will be changed into ReproCELL Europe Ltd. after the merger.  Full Article

ReproCell appoints Daitsuke Utsui as CFO
Friday, 13 May 2016 02:20am EDT 

ReproCell <4978.T>:Says it appoints Daitsuke Utsui as CFO, effective June 24.  Full Article

ReproCELL lowers consolidated full-year outlook for FY 2016
Monday, 2 May 2016 04:30am EDT 

ReproCELL Inc:Says the company lowered the consolidated full-year outlook for the FY ended March 2016.Revenue forecast decreased to 1,066 million yen from 1,530 million yen.Operating profit forecast decreased to a loss of 1,023 million yen from a loss of 555 million yen.Ordinary profit forecast decreased to a loss of 1,168 million yen from a loss of 495 million yen.Net profit forecast decreased to a loss of 1,960 million yen from a loss of 495 million yen.Earnings per share decreased to a loss of 36.13 yen from a loss of 9.53 yen.Comments that decreased sales and impact of expense and exchange rate are the main reasons for the forecast.  Full Article

ReproCELL completes off-floor distribution
Tuesday, 8 Dec 2015 07:30pm EST 

ReproCELL Inc:Completed the off-floor distribution of 1,056,400 shares of its common stock on Dec. 9.Says at the price of 401 yen per share.  Full Article

ReproCELL to offer off-floor distribution of shares
Tuesday, 8 Dec 2015 02:15am EST 

ReproCELL Inc:To offer an off-floor distribution of 1,056,400 shares of its stock at the price of 401 yen per share, on the Tokyo Stock Exchange on Dec. 9.Says the limitation for purchase of the distribution is up to 30,000 shares for each customer.  Full Article

More From Around the Web

BRIEF-ReproCell announces exercise of options

* Says 600 of its 12th series options were exercised to 600,000 shares as of May 25